Qing Sarah Yuan - 07 Mar 2022 Form 3 Insider Report for Sigilon Therapeutics, Inc.

Role: CTOO
Signature: /s/ Matthew Kowalsky, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 07 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 10 Mar 2022, 15:28:59 UTC
Next filing: 04 Apr 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney